Review reveals advancements in schwann cell therapies and biomaterial scaffolds for spinal cord injury regeneration, indicating a new treatment horizon.
Key Points
Improved axon growth achieved with combined schwann cell and biomaterial strategies, enhancing regenerative outcomes for spinal cord injury.
Key evidence shows that integrating biomaterials with schwann cells can enhance survival and spatial distribution in preclinical models.
Therapeutic examination involves various biomaterial types, including hydrogels and nanofibers, demonstrating significant benefits for spinal cord regeneration.
Next-generation approaches may enable effective clinical solutions, emphasizing the need for integrated therapies in spinal cord injury recovery.